Stryker hip settlements have been reached in eight of the nine Stryker Rejuvenate hip lawsuits involved in a court-ordered mediation process under the jurisdiction of the Superior Court of New Jersey for Bergen County. Close to 1500 Stryker Rejuvenate recall lawsuits have been filed across... Read More

Bayer has indicated it intends to provide thousands of Yaz settlements to plaintiffs with cases currently pending in the United States. According to the company’s 2013 Annual Report, Bayer plans to spend approximately $1.69 billion to settle lawsuits alleging blood clots and other venous disorders,... Read More

Increased skepticism and closer scrutiny of the benefits and risks of testosterone therapy is beginning to emerge in the wake of several research reports highlighting their potential danger, according to a recent New York Times story by Roni Caryn Rabin. However, given the wild popularity these... Read More

The opening witness in the first “bellwether” Actos cancer trial told the jury about drug manufacturer Takeda’s pretrial misconduct.  The case is the first of several scheduled in the ongoing Actos Multidistrict Litigation (MDL) in federal court in Louisiana. Terrence Allen and his wife’s lawsuit... Read More

In the midst of growing concern about the safety of widely popular testosterone therapy drugs, consumer advocacy watchdog group Public Citizen has just petitioned the U.S. Food and Drug Administration to place bold, stark labeling on such medications alerting users to the increased risk of... Read More

The rambling, sometimes comical list of drug side effects in TV commercials may soon be a thing of the past, as the FDA begins a new study to determine the impact of such direct-to-consumer ads. Health regulators are concerned that the list, which often names... Read More

As Pradaxa lawsuits continue to mount, some of the plaintiffs filing complaints are attempting to hold additional parties accountable for injuries related to the anticoagulant drug. Nearly all the plaintiffs filing complaints are naming Boehringer Ingelheim as the primary defendant. However, The Spectator reports that... Read More

In response to two recent studies of the possible connection between testosterone therapy and an increased risk of heart attack, stroke and death, the U.S. Food and Drug Administration (FDA) has announced that it will conduct a formal assessment and report on its conclusions and... Read More